|Articles|September 7, 2013

Compliance by Design and Compliance Master Plans

Video with Paul Pluta

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

pharmaceutical industrial washing and drying machine | Image Credit: ©Kadmy - stock.adobe.com

Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning

ByThomas Altmann,Donald Singer,Stefan-Julian Frohberger

October 10th 2025

Genetic Engineering. The study of the structure of DNA and RNA, the introduction of changes at the gene level. Modern medical research of stem cells. 3D illustrations | Image Credit: © Siarhei - © Siarhei - stock.adobe.com

FDA Designation and UK Approval for AAVB-039 Highlight Progress in Complex Gene Therapy Development

ByFeliza Mirasol

October 2nd 2025

Doctor technology AI integrates big data analytics with clinical research, enabling precise treatment plans tailored to individual patient needs and genetic profiles. | Image Credit: © Suriyo - © Suriyo - stock.adobe.com

New FDA Guidance Utilizes Real-World Data and AI for Postmarket CGT Surveillance

ByFeliza Mirasol

October 1st 2025

Young woman with genetic research in the laboratory research of cancer diseases | Image Credit: © luchschenF - © luchschenF - stock.adobe.com

Implications of FDA’s New Draft Guidance on Innovative Trial Design for Rare-Disease CGTs

ByFeliza Mirasol

September 30th 2025

Double helix DNA molecule with modified genes , Correcting mutation by genetic engineering | Image Credit: © nobeastsofierce - stock.adobe.com

New FDA RMAT Guidance's Impact on Clinical, CMC Strategies

ByPatrick Lavery

September 29th 2025

Compliance by Design and Compliance Master Plans

Newsletter

Related Content

Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning

FDA Designation and UK Approval for AAVB-039 Highlight Progress in Complex Gene Therapy Development

New FDA Guidance Utilizes Real-World Data and AI for Postmarket CGT Surveillance

Implications of FDA’s New Draft Guidance on Innovative Trial Design for Rare-Disease CGTs

New FDA RMAT Guidance's Impact on Clinical, CMC Strategies

Trending on BioPharm International

Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report

Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D

Everything to Know About Cell and Gene Therapy in 2025

Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)

Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)